PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation (PROSPECT-AF)

University Hospital, Lille

Status: Enrolling

Conditions: Atrial Fibrillation

Treatments: Procedure: atrial fibrillation catheter ablation

Study type: Observational

Funder types: Other

Identifiers

NCT05009797

2020-A02171-38 (Other Identifier)

2018_83

Details and patient eligibility

About

Atrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood.

The aim of the PROSPECT-AF study is to assess the predictors of AF recurrence within the 3 years following ablation using clinical variables and innovative biomarkers in a prospective cohort of 750 patients undergoing atrial fibrillation catheter ablation.

The secondary aims are to assess the incidence of major adverse cardiovascular outcomes (MACE) and the incidence of major bleeding within the 3 years Wolfing catheter ablation.

Enrollment: 750 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient undergoing atrial fibrillation catheter ablation
• Able to give their consent

Exclusion criteria

• Childs
• Patient under guardianship
• Patients unable to give their consent
• Pregnancy

Trial design

750 participants in 1 patient group

Patients undergoing atrial fibrillation catheter ablation

Description:

Patients undergoing scheduled atrial fibrillation catheter ablation.

Treatment:

Procedure: atrial fibrillation catheter ablation